HQ Function

The Andover headquarters housed the company's main research laboratories, process development, clinical GMP manufacturing capabilities, and corporate administrative functions. It was central to their drug development efforts.

Notable Features:

The facility included advanced laboratories for virology research and development, along with in-house capabilities for producing clinical-grade oncolytic viruses, which is a significant asset for a biotech of its stage.

Work Culture:

Prior to its financial difficulties, the work culture at Oncorus likely reflected a dynamic, science-driven environment typical of clinical-stage biotechnology companies: focused on innovation, collaboration, and a strong sense of mission to address unmet needs in cancer treatment.

HQ Significance:

This location was the nerve center for Oncorus's pioneering work in oncolytic viral immunotherapies, enabling the development of its novel product candidates from discovery through to clinical trials.

Values Reflected in HQ: The investment in advanced R&D and manufacturing facilities at the headquarters underscored Oncorus's commitment to scientific excellence, innovation, and self-sufficiency in key aspects of drug development.

Location:

Oncorus, Inc.'s operations were primarily concentrated in the United States, with its headquarters in Andover, MA, and an additional site in Cambridge, MA. While its therapeutic ambitions were global, the company did not maintain significant physical operations or offices internationally prior to its bankruptcy. Its global engagement was mainly through participation in international scientific conferences and potential future partnerships or clinical trials.

Street Address:

500 River Ridge Drive

City:

Andover

State/Province:

Massachusetts

Country:

USA